XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 25, 2022   111,132,993    
Beginning balance at Dec. 25, 2022 $ 541,226,000 $ 111,000 $ 1,212,716,000 $ (671,601,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (85,970,000)     (85,970,000)
Exercise of stock options (in shares) 888,309 888,309    
Exercise of stock options $ 5,111,000 $ 1,000 5,110,000  
Issuance of common stock related to restricted shares (in shares)   407,139    
Shares repurchased for employee tax withholding (in shares)   (6,894)    
Shares repurchased for employee tax withholding (166,000)   (166,000)  
Stock-based compensation expense 40,133,000   40,133,000  
Ending balance (in shares) at Sep. 24, 2023   112,421,547    
Ending balance at Sep. 24, 2023 500,334,000 $ 112,000 1,257,793,000 (757,571,000)
Beginning balance (in shares) at Jun. 25, 2023   111,946,454    
Beginning balance at Jun. 25, 2023 511,324,000 $ 112,000 1,243,728,000 (732,516,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (25,055,000)     (25,055,000)
Exercise of stock options (in shares)   367,067    
Exercise of stock options $ 2,601,000 $ 0 2,601,000  
Issuance of common stock related to restricted shares (in shares)   108,361    
Shares repurchased for employee tax withholding (in shares) (335)      
Shares repurchased for employee tax withholding $ (2,000)      
Stock-based compensation expense 11,466,000   11,466,000  
Ending balance (in shares) at Sep. 24, 2023   112,421,547    
Ending balance at Sep. 24, 2023 500,334,000 $ 112,000 1,257,793,000 (757,571,000)
Beginning balance (in shares) at Dec. 31, 2023   112,639,146    
Beginning balance at Dec. 31, 2023 482,597,000 $ 113,000 1,267,469,000 (784,985,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (61,343,000)     (61,343,000)
Exercise of stock options (in shares) 1,507,226 1,507,226    
Exercise of stock options $ 9,704,000 $ 3,000 9,701,000  
Issuance of common stock related to Spyce milestone achievement (in shares)   208,042    
Issuance of common stock related to Spyce milestone achievement $ 2,132,000      
Issuance of common stock related to performance stock units (in shares) 900,000      
Issuance of common stock related to restricted shares (in shares)   369,355    
Shares repurchased for employee tax withholding (in shares)   (281)    
Stock-based compensation expense $ 30,214,000   30,214,000  
Ending balance (in shares) at Sep. 29, 2024   115,623,488    
Ending balance at Sep. 29, 2024 463,304,000 $ 116,000 1,309,516,000 (846,328,000)
Beginning balance (in shares) at Jun. 30, 2024   114,139,532    
Beginning balance at Jun. 30, 2024 470,135,000 $ 114,000 1,295,533,000 (825,512,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (20,816,000)     (20,816,000)
Exercise of stock options (in shares)   479,042    
Exercise of stock options 4,300,000 $ 2,000 4,298,000  
Issuance of common stock related to performance stock units (in shares)   900,000    
Issuance of common stock related to restricted shares (in shares)   105,009    
Shares repurchased for employee tax withholding (in shares)   (95)    
Stock-based compensation expense 9,685,000   9,685,000  
Ending balance (in shares) at Sep. 29, 2024   115,623,488    
Ending balance at Sep. 29, 2024 $ 463,304,000 $ 116,000 $ 1,309,516,000 $ (846,328,000)